Surgical Management of the Axilla in Breast Cancer Patients with Negative Sentinel Lymph Node: A Method to Reduce False-Negative Rate

[1] Veronesi U(2010)Sentinel lymph node biopsy in breast cancer Ann Surg 251 595-600

[2] Viale G(2010)Long-term follow-up confirms the oncologic safety of sentinel node biopsy without axillary dissection in node-negative breast cancer patients Ann Surg 251 601-603

[3] Paganelli G(2003)A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 546-553

[4] Giuliano AE(2007)Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol 8 881-888

[5] Chung AP(2010)Impact of omission of axillary lymph node dissection after negative sentinel lymph node biopsy: 70-month follow-up Ann Surg Oncol 17 2126-2131

[6] Veronesi U(2010)Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol 11 927-933

[7] Paganelli G(2006)Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial J Natl Cancer Inst 98 599-609

[8] Viale G(2017)Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update J Clin Oncol 35 561-564

[9] Krag DN(2017)Sentinel lymph node biopsy in breast cancer: a clinical review and update J Breast Cancer 20 217-1411

[10] Anderson SJ(2018)Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice Science 359 1408-1407

[1] Veronesi U(2010)Sentinel lymph node biopsy in breast cancer Ann Surg 251 595-600

[2] Viale G(2010)Long-term follow-up confirms the oncologic safety of sentinel node biopsy without axillary dissection in node-negative breast cancer patients Ann Surg 251 601-603

[3] Paganelli G(2003)A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 546-553

[4] Giuliano AE(2007)Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol 8 881-888

[5] Chung AP(2010)Impact of omission of axillary lymph node dissection after negative sentinel lymph node biopsy: 70-month follow-up Ann Surg Oncol 17 2126-2131

[6] Veronesi U(2010)Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol 11 927-933

[7] Paganelli G(2006)Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial J Natl Cancer Inst 98 599-609

[8] Viale G(2017)Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update J Clin Oncol 35 561-564

[9] Krag DN(2017)Sentinel lymph node biopsy in breast cancer: a clinical review and update J Breast Cancer 20 217-1411

[10] Anderson SJ(2018)Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice Science 359 1408-1407